Additional benefit of hemostatic sealant in preservation of ovarianreserve during laparoscopic ovarian cystectomy: A multi-center, randomized controlled trial

Human Reproduction

Volumn 29, Issue 8, 2014, Pages 1659-1665

  Song, Taejong ^a   Lee, San Hui ^b   Kim, Woo Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

AMH; Ovarian cystectomy; Ovarian cysts; Ovarian reserve

Indexed keywords

GELATIN; HEMOSTATIC AGENT; MUELLERIAN INHIBITING FACTOR; SEALANT; THROMBIN; FLOSEAL MATRIX; GELATIN SPONGE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; LAPAROENDOSCOPIC SINGLE SITE SURGERY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVARIAN BLEEDING; OVARIAN RESERVE; OVARY CYST; PEROPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERUM; TREATMENT OUTCOME; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; GYNECOLOGIC SURGERY; LAPAROSCOPY; OVARIAN CYSTS; PROCEDURES;

ADULT; ANTI-MULLERIAN HORMONE; FEMALE; GELATIN SPONGE, ABSORBABLE; GYNECOLOGIC SURGICAL PROCEDURES; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; LAPAROSCOPY; OVARIAN CYSTS; OVARIAN RESERVE; TREATMENT OUTCOME;

EID: 84904307360     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu125     Document Type: Article

References (28)

1. Almog B, Sheizaf B, Shalom-Paz E, Shehata F, Al-Talib A, Tulandi T. Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilization. Fertil Steril 2010;94:2340-2342.
2. Angioli R, Muzii L, Montera R, Damiani P, Bellati F, Plotti F, ZulloMA, Oronzi I, Terranova C, Panici PB. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol 2009;16:153-156.
3. Benaglia L, Somigliana E, Vighi V, Ragni G,Vercellini P, Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod 2010; 25:678-682.
4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
5. Busacca M, Riparini J, Somigliana E, Oggioni G, Izzo S, Vignali M, Candiani M. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 2006;195:421-425.
6. Candiani M, Barbieri M, Bottani B, Bertulessi C, Vignali M, Agnoli B, Somigliana E, Busacca M. Ovarian recovery after laparoscopic enucleation of ovarian cysts: insights from echographic short-term postsurgical follow-up. J Minim Invasive Gynecol 2005;12:409-414.
7. Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73:859-861.
8. Coric M, Barisic D, Pavicic D, Karadza M, Banovic M. Electrocoagulation versus suture after laparoscopic stripping of ovarian endometriomas assessed by antral follicle count: preliminary results of randomized clinical trial. Arch Gynecol Obstet 2011;283:373-378.
9. Di Prospero F, Micucci G. Is operative laparoscopy safe in ovarian endometriosis? Reprod Biomed Online 2009;18:167.
10. Ebert AD, Hollauer A, Fuhr N, Langolf O, Papadopoulos T. Laparoscopic ovarian cystectomy without bipolar coagulation or sutures using a gelantine-thrombin matrix sealant (FloSeal): first support of a promising technique. Arch Gynecol Obstet 2009;280:161-165.
11. Esinler I, Bozdag G, Aybar F, Bayar U, Yarali H. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas. Fertil Steril 2006;85:1730-1735.
12. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323-327.
13. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057-4063.
14. Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Bayasula B, Nakamura T, Manabe S, Kikkawa F. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011;26:904-910.
15. Hwu YM, Wu FS, Li SH, Sun FJ, Lin MH, Lee RK. The impact of endometrioma and laparoscopic cystectomy on serum anti-Mullerian hormone levels. Reprod Biol Endocrinol 2011;9:80.
16. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008;90:737-743.
17. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, Volpe A. Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004; 19:2738-2741.
18. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21:3103-3107.
19. McIlveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod 2007; 22:778-785.
20. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012;97:3146-3154.
21. Seifer DB, Maclaughlin DT. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 2007; 88:539-546.
22. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468-471.
23. Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril 2012;98:1531-1538.
24. Sonmezer M, Taskin S, Gemici A, Kahraman K, Ozmen B, Berker B, Atabekoglu C. Can ovarian damage be reduced using hemostatic matrix during laparoscopic endometrioma surgery? A prospective, randomized study. Arch Gynecol Obstet 2013;287:1251-1257.
25. Sowers M,McConnell D, Gast K, Zheng H, NanB, McCarthy JD, Randolph JF. Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril 2010;94:1482-1486.
26. Tsolakidis D, Pados G, Vavilis D, Athanatos D, Tsalikis T, Giannakou A, Tarlatzis BC. The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril 2010; 94:71-77.
27. Var T, Batioglu S, Tonguc E, Kahyaoglu I. The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study. Fertil Steril 2011; 95:2247-2250.
28. Yoon BS, Kim YS, Seong SJ, Song T, Kim ML, Kim MK, Paek JY. Impact on ovarian reserve after laparoscopic ovarian cystectomy with reduced port number: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2014;176:34-38.